Gynuity Health Projects clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 113 studies whose lead sponsor is Gynuity Health Projects. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 27, 2025.
Keep track of what changes. Save the Gynuity Health Projects studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Gynuity Health Projects leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 113. Browse all 113 →
- Evaluation of Telemedicine Medical Abortion Service in EcuadorRecruitingNCT06270056
- Assessing the Efficacy and Acceptability of Two Missed Period Pills RegimensNot yet recruitingNCT06492889Phase 2/3
- Medication Abortion With Autonomous Self-Assessment ProjectCompletedNCT05278780Not applicable
- Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan.CompletedNCT05459142
- Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.CompletedNCT05028387
- MA-ASAP at Independent Abortion Clinics: A Demonstration ProjectCompletedNCT05781061Not applicable
- Feasibility of Medical Abortion by Telemedicine in MexicoCompletedNCT03931460
- Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 WeeksTerminatedNCT05119439Phase 4
- Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' GestationCompletedNCT05207644Phase 2
- Feasibility of Telemedicine Medical AbortionCompletedNCT04599725
- Feasibility of Medical Abortion by Direct-to-Consumer TelemedicineCompletedNCT02513043
- Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in NepalCompletedNCT05046041Phase 4
- Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"Status unknownNCT04676776Phase 2
- Non-surgical Alternatives to Treatment of Failed Medical AbortionTerminatedNCT02704481Phase 4
- Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before AbortionTerminatedNCT04232189
- Urine and Serum Concentrations of Pregnancy-Associated Compounds During GestationCompletedNCT03552055
- Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in ColombiaTerminatedNCT04063904Phase 4
- Assessing Medical Menstrual Regulation in the United StatesStatus unknownNCT03972358Phase 2
- Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control StudyCompletedNCT02610972
- Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina FasoStatus unknownNCT03269279Phase 3
- Outpatient Service for Mid-trimester Termination of PregnancyCompletedNCT03346629Phase 4
- Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal DeathTerminatedNCT02633761Phase 3
- Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and MexicoCompletedNCT02381210
- Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled TrialTerminatedNCT02342002Phase 4
- Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A SurveyCompletedNCT02611011
- Oral Antihypertensive Regimens for Management of Hypertension in PregnancyCompletedNCT01912677Phase 4
- Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion ServicesCompletedNCT03207880Not applicable
- Introduction of UBT for PPH Management in Three CountriesCompletedNCT02910310Not applicable
- Measuring hCG Levels in Pregnant WomenCompletedNCT02763176
- Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western UkraineCompletedNCT02981030Phase 4
- Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations ResearchCompletedNCT02707653Not applicable
- The Association Between Shock Index and Severity of Postpartum Blood LossCompletedNCT03135158
- IV Versus IM Administration of Oxytocin for Postpartum BleedingCompletedNCT02954068Phase 4
- Acceptability and Feasibility of Medical Abortion in SingaporeCompletedNCT02985229Phase 3
- Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum HemorrhageCompletedNCT02805426Phase 4
- Simplifying First Trimester Medical Abortion Follow-upCompletedNCT03014193
- Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy TestsCompletedNCT02570204Not applicable
- Simplified Medical Abortion Screening: A Pilot Demonstration ProjectCompletedNCT02381223
- Treatment of Postpartum Hemorrhage With Misoprostol: Fever StudyCompletedNCT02163616Phase 3
- Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and MexicoStatus unknownNCT02381197
- Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-UpCompletedNCT02299401Phase 2/3
- A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate RegimenCompletedNCT02091401Phase 4
- Misoprostol as First Aid Measure to Address Excessive Postpartum BleedingStatus unknownNCT02853552Phase 4
- Misoprostol for the Treatment of Incomplete AbortionCompletedNCT00670761Not applicable
- Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in UkraineCompletedNCT02415894
- Chart Review Study of Medical AbortionCompletedNCT02841072
- A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester AbortionStatus unknownNCT02708446Phase 4
- Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of GestationCompletedNCT02314754Phase 4
- Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsCompletedNCT01508429Not applicable
- A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 WeeksCompletedNCT02720991Phase 4